bionikk: the first trial study in mccrcc
Published 3 years ago • 47 plays • Length 1:50Download video MP4
Download video MP3
Similar videos
-
9:48
bionikk trial update
-
2:24
current and emerging treatment strategies for patients with mccrcc
-
1:03
dr. hutson discusses the phase iii atlas study in rcc
-
2:40
updates on the cabopre phase ii trial in patients with metastatic renal cell carcinoma
-
4:21
biomarker development in rcc and uc
-
9:57
how to select 1st line therapy for metastatic renal cell cancer?
-
38:47
renal cell carcinoma
-
3:12
opdivo (nivolumab) the immunotherapy cancer treatment
-
1:42
dr. mcdermott on immotion150 trial in rcc
-
11:18
first-line icis in advanced non-clear cell rcc
-
25:28
systemic treatment of metastatic renal cell cancer: what is state of the art in 2020? - l. albiges
-
2:31
changing the standard of care in previously treated metastatic renal cell carcinoma
-
1:20
renal cell carcinoma: the emulsion and checkmate 214 trials
-
1:43
rcc data at esmo 2020
-
2:02
tki and checkpoint inhibitor combinations for kidney cancer: the immotion151 trial
-
1:54
checkmate 214 trial in rcc updates
-
2:36
safety and efficacy of nivolumab in mrcc: final analysis from the nivoren study
-
1:03
treating patients with rcc in 2020 and beyond
-
32:46
lenvatinib pembrolizumab in rcc, the clear trial with karine tawagi
-
5:16
potential new treatments in renal cell carcinoma
-
1:12
cabozantinib for advanced renal cell carcinoma: the meteor and cabosun trials
-
1:51
inmunosun-sogug trial: sunitinib second line metastatic rcc